Pleopharma, INC.
At a glance
EmployeesNot reported
In business since2019
HeadquartersMalvern, PA
US patents2
SAM.gov UEINSW8A6YH85C1
CAGE code9VNF4
Incorporated inDE
- Phase 2
- healthcare providers
- pharmaceutical
- substance abuse
Named on the company’s own website, read JUL 29, 2026
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
2 US patents granted 2024–2025, 2 of them in the five years to SEP 2025.
Pharmaceuticals 2
- Methods and compositions for treating cannabis use disorder and mitigating cannabinoid withdrawalUS 12,268,659 · granted APR 8, 2025
- Methods and compositions for treating cannabis use disorder and mitigating cannabinoid withdrawalUS 11,931,334 · granted MAR 19, 2024
Granted to Pleopharma, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Pleopharma, INC. | Malvern | PA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.


